Skip to main content Skip to main navigation menu Skip to site footer

Ondansetron and metoclopramide: a comparative analysis of effectiveness and cost in hospitalized patients with hyperemesis gravidarum

  • Lonah ,
  • Purwantyastuti ,
  • Nafrialdi ,
  • Irwinda R ,
  • Via Dolorosa Halilintar ,

Abstract

Background: Hyperemesis Gravidarum (HG) is nausea and vomiting which interfere pregnant women’s daily activities.
Ondansetron (ODN) is often used off label for the treatment of hyperemesis gravidarum. This study aimed to analyze the
efficacy and cost of ondansetron versus metoclopramide (MCP), a drug that has been used in the standard regimen for the
treatment of HG. patients in the largest hospital in Jakarta during year 2012 to 2016.
Method: The research was conducted with a cross-sectional study design on respondents with criteria, namely pregnant
patients hospitalized with HG at Dr. Cipto Mangunkusumo Hospital from 2012-2016. Assessment of clinical effectiveness was
carried out by looking at the day’s duration until the symptoms of nausea and vomiting stopped. Furthermore, a cost analysis
was carried out by calculating the average direct medical costs associated with the HG’s condition.
Result: The effectiveness of both antiemetics was not statistically significant (p = 0.370). The average cost per patient with
ondansetron compared to metoclopramide was not significantly different (p = 0,966).
Conclusion: There was no difference in the effectiveness and cost of ODN versus MCP for the treatment of hyperemesis
gravidarum.

References

  1. London V, Grube S, Sherer DM, Abulafia O. Hyperemesis gravidarum: A review of recent literature. Pharmacology. 2017;100(3-4):161-171. doi:10.1159/000477853
  2. Wegrzyniak LJ, Repke JT, Ural SH. Treatment of hyperemesis gravidarum. Rev Obstet Gynecol. 2012;2(1923):1375. doi:10.1136/bmj.2.1923.1375
  3. Suriati I, Yusnidar Y. Causes of Hyperemesis Gravidarum. J Kebidanan. 2021;11(1):76-81. doi:10.31983/jkb.v11i1.6398
  4. Kaya C, Gasimova R, Ekin M, Yasar L. Hyperemesis Gravidarum: Current Approaches for the Diagnosis and Treatment. J Pregnancy Child Heal. 2016;03(06):2-4. doi:10.4172/2376-127x.1000296
  5. Nurmi M, Rautava P, Gissler M, Vahlberg T, Polo-Kantola P. Incidence and risk factors of hyperemesis gravidarum: A national register-based study in Finland, 2005-2017. Acta Obstet Gynecol Scand. 2020;99(8):1003-1013. doi:10.1111/aogs.13820
  6. Mullin P, Ching C, Shoenberg F, et al. Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2012;25(6):1-7. doi:10.3109/14767058.2011.598588.Risk
  7. Piwko C, Koren G, Babashov V, Vicente C, Einarson TR. Economic burden of nausea and vomiting of pregnancy in the USA. J Popul Ther Clin Pharmacol. 2013;20(2):149-160.
  8. Heitmann K, Holst L, Lupattelli A, Maltepe C, Nordeng H. Treatment of nausea in pregnancy: A crosssectional multinational web-based study of pregnant women and new mothers. BMC Pregnancy Childbirth. 2015;15(1). doi:10.1186/s12884-015-0746-2
  9. Segni H, Jarso H, Ayana D. Prevalence of Hyperemesis Gravidarum and Associated Factors Among Pregnant Women at Jimma University Medical Center. EC Gynaecol. 2016;3(December):376-387. https://www.researchgate.net/publication/312040870
  10. Lee NM, Saha S. Nausea and Vomiting of Pregnancy. Gastroenterol Clin North Am. 2011;40(2):309-334. doi:10.1016/j.gtc.2011.03.009
  11. Colvin L, Gill AW, Slack-Smith L, Stanley FJ, Bower C. Off-label use of ondansetron in pregnancy in Western Australia. Biomed Res Int. 2013;2013. doi:10.1155/2013/909860
  12. Moradiha F, Farahmandrad S, Gholami H. Comparison of the effectiveness of ondansetron versus metoclopramide in hyperemesis gravidarum: A randomized clinical trial. Front Emerg Med. 2021;6(1):1-6. doi:10.18502/fem.v6i1.7677
  13. Paskana K, Gusnidarsih V. Hubungan Paritas dengan Kejadian Hiperemesis Gravidarum pada Ibu Hamil. J Asuhan Ibu dan Anak. 2020;5(2):25-29. doi:10.1136/bmj.c846
  14. Tan A, Lowe S, Henry A. Nausea and vomiting of pregnancy: Effects on quality of life and day-to-day function. Aust New Zeal J Obstet Gynaecol. 2018;58(3):278-290. doi:10.1111/ajo.12714
  15. Dormuth CR, Winquist B, Fisher A, et al. Comparison of Pregnancy Outcomes of Patients Treated with Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. JAMA Netw Open. 2021;4(4):1-14. doi:10.1001/jamanetworkopen.2021.5329
  16. Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: A randomized controlled trial. Obstet Gynecol. 2014;123(6):1272-1279. doi:10.1097/AOG.0000000000000242

How to Cite

Lonah, Purwantyastuti, Nafrialdi, Irwinda R, & Via Dolorosa Halilintar. (2022). Ondansetron and metoclopramide: a comparative analysis of effectiveness and cost in hospitalized patients with hyperemesis gravidarum. Bali Medical Journal, 11(1), 438–442. https://doi.org/10.15562/bmj.v11i1.3223

HTML
0

Total
0

Share